Form 8-K - Current report:
SEC Accession No. 0001764013-22-000002
Filing Date
2022-01-05
Accepted
2022-01-05 07:38:13
Documents
27
Period of Report
2022-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20220105.htm   iXBRL 8-K 35649
2 EX-99.1 exhibit991.htm EX-99.1 17005
6 GRAPHIC exhibit991001.jpg GRAPHIC 97302
7 GRAPHIC exhibit991002.jpg GRAPHIC 205043
8 GRAPHIC exhibit991003.jpg GRAPHIC 142357
9 GRAPHIC exhibit991004.jpg GRAPHIC 140266
10 GRAPHIC exhibit991005.jpg GRAPHIC 112720
11 GRAPHIC exhibit991006.jpg GRAPHIC 96179
12 GRAPHIC exhibit991007.jpg GRAPHIC 99137
13 GRAPHIC exhibit991008.jpg GRAPHIC 110979
14 GRAPHIC exhibit991009.jpg GRAPHIC 67199
15 GRAPHIC exhibit991010.jpg GRAPHIC 117537
16 GRAPHIC exhibit991011.jpg GRAPHIC 134643
17 GRAPHIC exhibit991012.jpg GRAPHIC 146910
18 GRAPHIC exhibit991013.jpg GRAPHIC 99931
19 GRAPHIC exhibit991014.jpg GRAPHIC 86266
  Complete submission text file 0001764013-22-000002.txt   2478728

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20220105.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20220105_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20220105_pre.xml EX-101.PRE 12642
21 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20220105_htm.xml XML 10825
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 22509446
SIC: 2836 Biological Products, (No Diagnostic Substances)